SPDR® Russell 2000 US Small Cap UCITS ETF EUR is a equity ETF from SPDR tracking the Russell 2000 US Small Cap index through physical replication. Domiciled in Ireland and launched in 2014, the fund manages about 4.7 bn € and charges a TER of 0.30% — 30 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
SPDR® Russell 2000 US Small Cap UCITS ETF EUR competes with 359 other products in the same class and region (Equity, USA): it ranks 29th by fund size and 253rd by ongoing cost, with a TER of 0.30% against a group median of 0.20%. It has been listed since 2014, 12 years of track record.
On a €10,000 investment the TER costs 30 € a year, against 20 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 3.4% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| Moog Inc | 0.4% |
| Hut 8 Corp. Common Stock | 0.4% |
| ViaSat Inc | 0.4% |
| BrightSpring Health Services, Inc. Common Stock | 0.4% |
| Cytokinetics Inc | 0.3% |
| MaxLinear Inc | 0.3% |
| Argan Inc | 0.3% |
| UMB Financial Corporation | 0.3% |
| Jfrog Ltd | 0.3% |
| Krystal Biotech Inc | 0.3% |
| Borsa Italiana | R2US | EUR |
| XETRA | ZPRR | EUR |
| Francoforte | ZPRR | EUR |
| London Stock Exchange | R2US | USD |
| London Stock Exchange | R2SC | GBP |
| Euronext Paris | R2US | EUR |
| SIX Swiss Exchange | R2US | CHF |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.